Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamar Amit

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Antioxidants & Redox Signaling|October 6, 2010
Does 1-(R)-aminoindan possess neuroprotective properties against experimental Parkinson's disease?Orly Weinreb, Orit Bar-Am, Ksenia Prosolovich, et al.
Molecular Neurobiology|August 1, 2012
Multi-target, neuroprotective and neurorestorative M30 improves cognitive impairment and reduces Alzheimer's-like neuropathology and age-related alterations in miceLana Kupershmidt, Tamar Amit, Orit Bar-Am, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
The neuroprotective mechanism of action of the multimodal drug ladostigilOrly Weinreb, Tamar Amit, Orit Bar-Am, et al.
BMC Neuroscience|December 19, 2008
Physiological and pathological aspects of Abeta in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelatorsYael Avramovich-Tirosh, Tamar Amit, Orit Bar-Am, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 19, 2002
Involvement of MAP kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagilineMerav Yogev-Falach, Tamar Amit, Orit Bar-Am, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 29, 2006
A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processingMerav Yogev-Falach, Orit Bar-Am, Tamar Amit, et al.
Journal of Neurochemistry|May 19, 2004
Regulation of protein kinase C by the anti-Parkinson drug, MAO-B inhibitor, rasagiline and its derivatives, in vivoOrit Bar-Am, Merav Yogev-Falach, Tamar Amit, et al.
Annals of the New York Academy of Sciences|September 24, 2005
Novel neuroprotective mechanism of action of rasagiline is associated with its propargyl moiety: interaction of Bcl-2 family members with PKC pathwayOrly Weinreb, Tamar Amit, Orit Bar-Am, et al.
Neurotoxicity Research|November 10, 2016
A Novel Iron Chelator-Radical Scavenger Ameliorates Motor Dysfunction and Improves Life Span and Mitochondrial Biogenesis in SOD1<sup>G93A</sup> ALS MiceSagit Golko-Perez, Tamar Amit, Orit Bar-Am, et al.
Annals of the New York Academy of Sciences|July 11, 2003
Amyloid processing and signal transduction properties of antiparkinson-antialzheimer neuroprotective drugs rasagiline and TV3326Moussa B H Youdim, Tamar Amit, Orit Bar-Am, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Antioxidants & Redox Signaling|October 6, 2010
Does 1-(R)-aminoindan possess neuroprotective properties against experimental Parkinson's disease?Orly Weinreb, Orit Bar-Am, Ksenia Prosolovich, et al.
Molecular Neurobiology|August 1, 2012
Multi-target, neuroprotective and neurorestorative M30 improves cognitive impairment and reduces Alzheimer's-like neuropathology and age-related alterations in miceLana Kupershmidt, Tamar Amit, Orit Bar-Am, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
The neuroprotective mechanism of action of the multimodal drug ladostigilOrly Weinreb, Tamar Amit, Orit Bar-Am, et al.
BMC Neuroscience|December 19, 2008
Physiological and pathological aspects of Abeta in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelatorsYael Avramovich-Tirosh, Tamar Amit, Orit Bar-Am, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 19, 2002
Involvement of MAP kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagilineMerav Yogev-Falach, Tamar Amit, Orit Bar-Am, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 29, 2006
A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processingMerav Yogev-Falach, Orit Bar-Am, Tamar Amit, et al.
Journal of Neurochemistry|May 19, 2004
Regulation of protein kinase C by the anti-Parkinson drug, MAO-B inhibitor, rasagiline and its derivatives, in vivoOrit Bar-Am, Merav Yogev-Falach, Tamar Amit, et al.
Annals of the New York Academy of Sciences|September 24, 2005
Novel neuroprotective mechanism of action of rasagiline is associated with its propargyl moiety: interaction of Bcl-2 family members with PKC pathwayOrly Weinreb, Tamar Amit, Orit Bar-Am, et al.
Neurotoxicity Research|November 10, 2016
A Novel Iron Chelator-Radical Scavenger Ameliorates Motor Dysfunction and Improves Life Span and Mitochondrial Biogenesis in SOD1<sup>G93A</sup> ALS MiceSagit Golko-Perez, Tamar Amit, Orit Bar-Am, et al.
Annals of the New York Academy of Sciences|July 11, 2003
Amyloid processing and signal transduction properties of antiparkinson-antialzheimer neuroprotective drugs rasagiline and TV3326Moussa B H Youdim, Tamar Amit, Orit Bar-Am, et al.
Pageof 9